United States · FDA National Drug Code directory
LAMIVUDINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60429-353_445d3e2e-7b0c-29ad-e063-6394a90a8ce0
- Product NDC
- 60429-353
- Form
- TABLET, FILM COATED
- Composition / generic term
- lamivudine
- Labeler
- Golden State Medical Supply, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20111202
- Source listing expiry
- 20261231
Source-listed ingredients
- LAMIVUDINE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED in 1 BOTTLE (60429-353-60) · 60429-353-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →